X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (793) 793
Publication (31) 31
Book Chapter (12) 12
Book Review (4) 4
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (643) 643
male (416) 416
female (377) 377
veno-occlusive disease (365) 365
hematology (340) 340
hepatic veno-occlusive disease - etiology (315) 315
transplantation (305) 305
adult (292) 292
oncology (276) 276
liver (245) 245
middle aged (233) 233
index medicus (230) 230
adolescent (224) 224
bone-marrow-transplantation (205) 205
immunology (200) 200
child (184) 184
hematopoietic stem cell transplantation - adverse effects (166) 166
bone marrow transplantation - adverse effects (155) 155
child, preschool (152) 152
risk factors (143) 143
hepatic venoocclusive disease (140) 140
infant (131) 131
venoocclusive disease (129) 129
hematopoietic stem cells (126) 126
hepatic veno-occlusive disease - chemically induced (115) 115
stem-cell transplantation (114) 114
children (111) 111
hepatic veno-occlusive disease - diagnosis (109) 109
treatment outcome (109) 109
hepatic veno-occlusive disease - drug therapy (107) 107
bone-marrow transplantation (106) 106
hematopoietic stem cell transplantation (106) 106
defibrotide (105) 105
retrospective studies (104) 104
hepatic veno-occlusive disease - prevention & control (96) 96
sinusoidal obstruction syndrome (96) 96
bone marrow transplantation (91) 91
chemotherapy (91) 91
transplantation, homologous (91) 91
diagnosis (88) 88
stem cells (87) 87
aged (86) 86
pediatrics (85) 85
hepatic veno-occlusive disease - pathology (76) 76
liver diseases (76) 76
toxicity (72) 72
stem cell transplantation (71) 71
hepatic veno-occlusive disease - therapy (67) 67
liver - pathology (66) 66
busulfan (65) 65
incidence (64) 64
hepatic veno-occlusive disease (63) 63
therapy (63) 63
polydeoxyribonucleotides - therapeutic use (60) 60
transplantation conditioning - adverse effects (57) 57
cyclophosphamide (56) 56
risk-factors (56) 56
vod (55) 55
complications and side effects (54) 54
care and treatment (53) 53
hepatic veno-occlusive disease - blood (53) 53
health aspects (52) 52
hepatic veno-occlusive disease - epidemiology (52) 52
prospective studies (51) 51
hepatic veno-occlusive disease - mortality (50) 50
veno‐occlusive disease (49) 49
bone marrow (47) 47
busulfan - administration & dosage (47) 47
venocclusive disease (46) 46
leukemia (45) 45
prevention (45) 45
cancer (44) 44
prognosis (44) 44
hematology, oncology and palliative medicine (42) 42
time factors (42) 42
young adult (42) 42
antineoplastic combined chemotherapy protocols - adverse effects (41) 41
fibrinolytic agents - therapeutic use (39) 39
surgery (39) 39
transplantation, autologous (39) 39
busulfan - adverse effects (38) 38
hepatic veno-occlusive disease - complications (38) 38
prophylaxis (38) 38
transplantation conditioning - methods (37) 37
animals (36) 36
tissue-plasminogen-activator (36) 36
versus-host-disease (36) 36
failure (35) 35
medicine & public health (35) 35
blood (34) 34
graft vs host disease - etiology (34) 34
hepatic veno-occlusive disease - physiopathology (34) 34
hepatotoxicity (34) 34
mortality (34) 34
pharmacokinetics (34) 34
survival analysis (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
research (33) 33
significant toxicity (33) 33
antineoplastic agents - adverse effects (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (779) 779
Japanese (10) 10
Chinese (5) 5
German (5) 5
Polish (3) 3
French (2) 2
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bone Marrow Transplantation, ISSN 0268-3369, 06/2001, Volume 27, Issue 11, pp. 1173 - 1180
Hepatic veno-occlusive disease (VOD) is one of the most serious complications in patients receiving stem cell transplantation (SCT). However, the cause of VOD... 
stem cell transplantation | vascular endothelial growth factor | veno-occlusive disease
Journal Article
SEMINARS IN THROMBOSIS AND HEMOSTASIS, ISSN 0094-6176, 06/2007, Volume 33, Issue 4, pp. 373 - 388
Journal Article
Journal of Clinical and Experimental Hepatology, ISSN 0973-6883, 2014, Volume 4, Issue 4, pp. 332 - 346
Hepatic sinusoidal obstruction syndrome (SOS) is an obliterative venulitis of the terminal hepatic venules, which in its more severe forms imparts a high risk... 
Endocrinology & Metabolism | Gastroenterology and Hepatology | Oxaliplatin | Herbal remedies | Liver | Hematopoietic stem cell transplantation | Colorectal cancer | VOD, veno-occlusive disease | NO, O-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | PML, promyelocytic leukemia protein | APRI, aspartate aminotransferase to platelet ratio | DF, defibrotide | VEGFR, vascular endothelial growth factor receptor | TIPS, transjugular intrahepatic porto-systemic shunt | FOLFOX, chemotherapy regimen containing Folinic acid, 5-Fluorouracil, and Oxaliplatin | UPLC-MS, ultra-performance liquid chromatography-mass spectrometry | l-NAME, N(G)-nitro-l-arginine methyl ester | RT, radiation therapy | TBI, total body irradiation | MOF, multi-organ failure | GVHD, graft-versus-host disease | RILD, radiation-induced liver disease | s-ICAM-1, soluble intercellular adhesion molecular-1 | VODI, veno-occlusive disease with immunodeficiency | V-PYRRO | GO, gemtuzumab ozogamicin | HSCT, hematopoietic stem cell transplantation | Seminar | SOS, sinusoidal obstruction syndrome | VEGF, vascular endothelial growth factor | AML, acute myeloid leukemia | RIC-HSCT, reduced-intensity conditioning hematopoietic stem cell transplantation | SEC, sinusoidal endothelial cells | Bmab, bevacizumab | GSTM1, glutathione S-transferase M1 | t-PA, tissue plasminogen activator | v-WF, von Willebrand factor | AST, aspartate aminotransferase
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 08/2003, Volume 32, Issue 4, pp. 349 - 354
Journal Article
Clinical Journal of Gastroenterology, ISSN 1865-7257, 2/2012, Volume 5, Issue 1, pp. 24 - 30
A 60-year-old man was admitted to Tenri Hospital complaining of erythema and abdominal distention. There were marked liver damage and hypereosinophilia. The... 
Steroid | Sinusoidal obstructive syndrome (SOS) | Medicine & Public Health | Sonazoid | Hepatology | Gastroenterology | Portal hypertension | Internal Medicine | Veno-occlusive disease (VOD) | Eosinophil | Hypertension | Corticosteroids | Ursodiol | Electric utilities | Universities and colleges | Prednisolone | Steroids
Journal Article
Archives of Disease in Childhood, ISSN 0003-9888, 07/2019, Volume 104, Issue 7, pp. e2 - e2
AimDefibrotide is licensed for the treatment of hepatic venous occlusive disease (VOD) following haematopoeitic stem cell transplant (HSCT). Up to April 2015... 
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2018, Volume 10, Issue 1, pp. e2018001 - e2018001
Hepatic Veno-Occlusive Disease (VOD) is a potentially severe complication of hematopoietic stem cell transplantation (HSCT). Here we report two patients... 
Veno-occlusive disease | VOD | Leukemia | Allogeneic Hematopietic stem cell transplantation | MULTIORGAN FAILURE | INFECTIOUS DISEASES | BONE-MARROW-TRANSPLANTATION | CHILDREN | SIGNIFICANT TOXICITY | COMPASSIONATE-USE | LIVER | HIGH-RISK POPULATION | COHORT | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
Medical Oncology, ISSN 0736-0118, 1999, Volume 16, Issue 3, pp. 166 - 176
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2009, Volume 147, Issue 4, pp. 554 - 560
Journal Article
Clinical Transplantation, ISSN 0902-0063, 11/2008, Volume 22, Issue 6, pp. 837 - 841
Palladino M, Miele L, Pompili M, Forgione A, Vellone V, Vecchio FM, Chiusolo P, Laurenti L, Gasbarrini G, Sica S, Grieco A. Severe veno-occlusive disease after... 
stem cells | liver biopsy | lymphoma | hematopoietic stem cell transplantation | autologous peripheral blood stem cell transplantat | defibrotide | Doppler ultrasound | veno-occlusive disease | autologous peripheral blood stem cell transplantation | veno‐occlusive disease | HSCT, hematopoietic stem cell transplantation | Liver biopsy | VOD, veno-occlusive disease | Autologous peripheral blood stem cell transplantation | rTPA, recombinant human tissue plasminogen activator | Bu, Busulfan | INR, international normalized ratio | Defibrotide | LDH, lactate dehydrogenase | CT, computed tomography | Veno-occlusive disease Abbreviations: ALT, alanine aminotransferase | Lymphoma | APBSCT, autologous peripheral blood stem cell transplantation | Hb, hemoglobin | Cy, cyclophosphamide | Stem cells | PTD, posttransplant day | AST, aspartate aminotransferase | WBC, white blood cell | Hematopoietic stem cell transplantation | US, ultrasound | SURGERY | SOLID TUMORS | BONE-MARROW-TRANSPLANTATION | VOD | HEPARIN | CHILDREN | TRANSPLANTATION | THERAPY | LIVER | COHORT | Hepatic Veno-Occlusive Disease - etiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Humans | Lymphoma, B-Cell - therapy | Aptamers, Nucleotide - therapeutic use | Male | Polydeoxyribonucleotides - therapeutic use | Transplantation, Autologous | Tissue Plasminogen Activator - therapeutic use | Biopsy | Fibrinolytic Agents - therapeutic use | Adult | Hepatic Veno-Occlusive Disease - drug therapy | Chemotherapy | Tissue plasminogen activator | Transplantation | Non-Hodgkin's lymphomas | Hematopoietic stem cells | Cancer
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 13, pp. 1656 - 1665
Journal Article